Technical Analysis for XDNA - iShares Genomics Immunology and Healthcare ETF

Grade Last Price % Change Price Change
B 32.120 0.06% 0.020
XDNA closed up 2.07 percent on Monday, April 29, 2024, on 43 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.06%
Strong but Oversold Other 0.06%
Gapped Up Strength 0.06%
Oversold Stochastic Weakness 0.06%
Narrow Range Bar Range Contraction 2.13%
Gapped Up Strength 2.13%
Oversold Stochastic Weakness 2.13%
MACD Bearish Centerline Cross Bearish 3.91%
Narrow Range Bar Range Contraction 3.91%
Gapped Down Weakness 3.91%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 2 days ago
Rose Above 10 DMA 2 days ago
Up 1 ATR 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

iShares Genomics Immunology and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. It invests in public equity markets of global region. It invests in stocks of companies operating across health care, health care equipment and services, pharmaceuticals, biotechnology and life sciences sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index, by using representative sampling technique. iShares Genomics Immunology and Healthcare ETF was formed on June 11, 2019 and is domiciled in the United States.
Classification

Keywords: Exchange Traded Funds Financial Markets Ishares Blackrock Spdr Synthetic Replication Biotechnology Pharmaceuticals Black Rock Fund Genomics

Is XDNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 45.08
52 Week Low 24.92
Average Volume 703
200-Day Moving Average 0.000
50-Day Moving Average 31.054
20-Day Moving Average 32.809
10-Day Moving Average 31.934
Average True Range 0.448
RSI (14) 50.50
ADX 18.7
+DI 48.001
-DI 47.473
Chandelier Exit (Long, 3 ATRs) 33.556
Chandelier Exit (Short, 3 ATRs) 32.254
Upper Bollinger Bands 34.919
Lower Bollinger Band 30.698
Percent B (%b) 0.33
BandWidth 12.863
MACD Line -0.044
MACD Signal Line 0.255
MACD Histogram -0.2985
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.100
Resistance 3 (R3) 32.100 32.100 32.100
Resistance 2 (R2) 32.100 32.100 32.100 32.100
Resistance 1 (R1) 32.100 32.100 32.100 32.100 32.100
Pivot Point 32.100 32.100 32.100 32.100 32.100
Support 1 (S1) 32.100 32.100 32.100 32.100 32.100
Support 2 (S2) 32.100 32.100 32.100 32.100
Support 3 (S3) 32.100 32.100 32.100
Support 4 (S4) 32.100